Cancer Model Analysis Summary
============================

Total simulations: 20
Successful simulations: 20
Success rate: 100.0%

Best overall result:
  Patient: Young
  Protocol: Continuous
  Efficacy Score: 36.42
  Tumor Reduction: 36.97%
  Final Resistance: 1.51%

Protocol Rankings (by average efficacy):
----------------------------------------
1. Continuous: 28.45
2. Adaptive: 27.75
3. Standard: 27.63
4. Hyperthermia: 27.36
5. Immuno_Combo: 21.62
